Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates Book Section


Authors: Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
Editors: Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C.
Article/Chapter Title: Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates
Keywords: long-term survival; hematologic response; complete remission; treatment-related mortality; organ response rate
Book Title: XIth International Symposium on Amyloidosis
ISBN: 978-1-4200-4281-8
Publisher: CRC Press/Taylor & Francis Group  
Publication Place: Boca Raton, FL
Date Published: 2008-01-01
Start Page: 234
End Page: 236
Language: English
ACCESSION: BIOSIS:PREV200800070657
PROVIDER: biosis
DOI: 10.1201/9781420043358.ch78
Notes: --- - Book Chapter: 78; Meeting - 11th International Symposium on Amyloidosis - Woods Hole, MA, USA - November 05 -09, 2006 - 6000 broken sound parkway nw, ste 300, boca raton, fl 33487-2742 usa - "Source: Biosis"
Altmetric Score
MSK Authors
  1. Julie T Feldstein
    288 Feldstein
  2. Adam D Cohen
    42 Cohen
  3. Raymond L Comenzo
    112 Comenzo
  4. Ping Zhou
    43 Zhou
  5. Hani Hassoun
    149 Hassoun
  6. Stephen D Nimer
    345 Nimer
  7. Martin Fleisher
    241 Fleisher
  8. Lilian M Reich
    77 Reich
  9. Daniel A Filippa
    102 Filippa
  10. Bradly D Clark
    15 Clark